Friday evening slide symposium.
Peters
M S
MS
Mayo Clinic, Rochester, Minnesota 55905.
Argenyi
Z
Z
Cerio
R
R
Finan
M
M
Gagne
E
E
Scott
G
G
D000328:Adult; D002277:Carcinoma / Q000473:pathology; D002675:Child, Preschool; D018223:Dermatofibrosarcoma / Q000473:pathology; D003875:Drug Eruptions; D005260:Female; D006086:Graft vs Host Disease / Q000139:chemically induced; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects; D006099:Granuloma / Q000150:complications / Q000473:pathology; D016575:Hidradenitis / Q000139:chemically induced; D015618:Histiocytosis, Sinus / Q000150:complications / Q000473:pathology; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects; D008206:Lymphatic Diseases / Q000150:complications / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000473:pathology; D009506:Nevus / Q000473:pathology; D010265:Paraproteinemias / Q000150:complications / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced / Q000150:complications / Q000473:pathology*; D013587:Syphilis / Q000473:pathology; D014973:Xanthomatosis / Q000150:complications / Q000473:pathology
D006912:Hydroxyquinolines; D016179:Granulocyte Colony-Stimulating Factor; C045282:roquinimex; D016178:Granulocyte-Macrophage Colony-Stimulating Factor